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Many chemotherapeutic regimens produce neutropenia, which predis-
poses to microbial infection. However, not all neutropenic individu-
als develop infections, so the ability to predict this outcome would be 
a powerful clinical tool. In this issue of the JCI, Malka et al. describe a 
dynamic system model of neutrophil bactericidal activity that confirms 
and extends the concept of critical neutrophil concentration. The authors 
demonstrate that when the neutrophil concentration approaches the 
critical concentration, bacterial populations in contact with them exhibit 
bistability. Their experimental findings raise the intriguing possibility 
of greater variability in bactericidal activity of neutrophils from healthy 
adults than heretofore recognized; their model predicts that this could 
have life-and-death consequences.
Although the link between neutropenia 
and infection risk is clear, the precise num-
ber of neutrophils required to maintain 
health remains a topic of intense research 
interest. Neutrophils continuously patrol 
the luminal surfaces of endothelial cells, 
searching for signs of infection or inflam-
mation. Such signs stimulate them to 
emigrate from blood into extravascular 
compartments (1). There, their armamen-
tarium of chemoattractant and phago-
cytosis-promoting plasma membrane 
opsonin and pattern-recognition recep-
tors enable them to phagocytose approxi-
mately 40–50 bacteria/neutrophil (2), 
and their preformed granule proteins and 
capacity to produce high intravacuolar 
concentrations of reactive oxygen species 
(3) enable them to kill their bacterial prey. 
The extracellular release of DNA-histone 
antimicrobial protein–containing nets (4) 
that entrap bacteria and kill yeast/fungi 
(5) extends their bactericidal and fungi-
cidal activities into their afterlives and 
further enhances their efficacy as guard-
ians of tissue sterility.
Chemotherapeutic agents that inhibit 
neutrophil biogenesis (6–8) and/or reduce 
their bactericidal activity (7) produce neu-
tropenia (i.e., <500,000 neutrophils/ml 
blood). Although neutropenia predisposes 
to infection, it has little direct effect on the 
sterility of blood because under most (9) — 
but not all (10) — conditions, hepatic and 
splenic macrophages are the cells primarily 
responsible for clearing bacteria from the 
circulation. Indeed, as suggested by Crosby 
(11) and supported by the studies of Wright 
et al. (12) and Koene et al. (13), it is the tis-
sue neutrophil concentration (N) that deter-
mines whether the small number of bacteria 
that breech mucosal surfaces each day will 
find fertile soil for growth, or be engulfed 
and killed. Thus, while a blood N value of 
5 × 105 neutrophils/ml is a call for vigilance, 
it is an imprecise measure of the likelihood 
of infection. This is so because blood is pri-
marily the conduit by which neutrophils 
travel from bone marrow to tissues, and 
the blood N reflects the sum of the rates at 
which neutrophils are produced and released 
from bone marrow into the circulation, and 
the rates at which they are consumed in tis-
sues (14) and/or recycled to spleen and bone 
marrow for destruction (15).
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can explore approximately 20 pl medium/
min, whereas in rabbit dermis, it can only 
explore approximately 4 pl dermis/min. 
Accordingly, 5 × 106 neutrophils/ml — the 
average concentration in human blood 
— is required for these cells to explore 1 
ml of a stirred bacterial suspension in 10 
minutes (i.e., 2 × 10–8 ml/neutrophil/min 
× 5 × 106 neutrophils × 10 min = 1 ml). 
Likewise, N of 2.5 × 107 neutrophils/ml or 
neutrophils/g rabbit dermis is required for 
neutrophils to explore 1 milliliter or gram 
of dermis in 10 minutes. Higher concen-
trations of neutrophils or longer explora-
tion times are required when B exceeds 107 
per milliliter stirred suspension (21) or 106 
per milliliter or gram of tissue (20).
Dynamic system model of neutrophil 
bactericidal activity: effects of 
bistability
The equation Malka et al. report here (25) 
and previously (26), namely dB(t)/dt = ρB(t)/
[1 + βB(t)] + s – δB(t) — (αNB(t)/[1 + γB(t) + 
ηN]), more accurately describes the rate of 
bacterial clearance than does the one previ-
ously reported by Li et al. (20, 21). This is 
because Malka et al. included the satura-
tion rate for bacterial growth (β) and the 
spontaneous rate of bacterial death [δB(t)]. 
The bacterial growth rate (ρ) behaves like a 
carrying capacity and saturates (βB) at high 
B values. The authors also included in their 
equation the rates of bacterial influx into 
the circulation or site of infection(s) and of 
spontaneous bacterial death. If these rates 
could be measured, their inclusion would 
add significantly to the predictive power of 
the equation; however, there are no estab-
lished methods at present for measuring 
them. Hence, Malka et al. assign them a 
value of 0, thereby eliminating this differ-
ence between the two groups’ equations.
They discovered that neutrophil-bacte-
ricidal activity in dermis of living rabbits 
and in fibrin gels is controlled by N and is 
independent of bacterial concentration (B), 
up to approximately 106 CFU/ml (20). They 
derived an equation that describes bacte-
rial killing as a function of N and bacterial 
growth rate (Figure 1A) and showed that it 
accurately described neutrophil-bactericidal 
activity in suspension (21), fibrin gels, and 
dermis of living rabbits (20). Additionally, 
they found the ratio of the experimentally 
determined bacterial growth rate (g) and 
neutrophil-bacterial killing rate constant 
(k) defined a new and extremely useful 
parameter: the critical neutrophil concen-
tration (CNC), namely, the N required to 
hold B constant (Figure 1A and refs. 20, 21). 
At N values below the CNC, B increases; at 
N above the CNC, B decreases. The CNC in 
stirred suspensions is approximately 4 × 105 
neutrophils/ml (21), very close to the clini-
cally determined value of 5 × 105 neutro-
phils/ml that defines neutropenia and char-
acterizes neutropenic patients in danger of 
infection (6–8). The CNC in fibrin gels and 
rabbit dermis is approximately 1 × 106 and 8 
× 106 neutrophils/ml, respectively (20), 2- to 
20-fold larger than in stirred suspensions. 
Apparently, evolution has taken note of the 
CNC, as the blood neutrophil concentration 
is no less than approximately 5 × 105 neu-
trophils/ml in all adult vertebrates (22–24).
What is the physical meaning of the 
CNC? The answer is evident from the 
value and units of k (ml/neutrophil/min), 
which for these purposes can be viewed as 
the volume of medium or tissue a neutro-
phil can explore per minute. For neutro-
phils in stirred suspension and in dermis 
of living rabbits, k is equivalent to 2 × 10–8 
and 4 × 10–9 ml/neutrophil/min, respec-
tively. In stirred suspension, 1 neutrophil 
A critical concentration of 
neutrophils is required to produce 
a net reduction in bacterial 
concentration
Since Robertson and Sia’s 1924 report (16), 
most in vitro studies of neutrophil-bacteri-
cidal activity have used neutrophils stirred 
continuously for 15–120 minutes at 37°C 
in plasma- or serum-containing medium 
with known concentrations of bacteria. The 
neutrophils then are lysed, and the con-
centration of viable bacteria remaining is 
measured by bacteriological colony assay. 
This system mimics neutrophil-bactericidal 
activity in blood. Comparatively few inves-
tigators have studied neutrophil-bacteri-
cidal activity in tissues of living animals 
or in three-dimensional gels composed of 
extracellular matrix proteins. The findings 
that extracellular matrix proteins exert 
potent physiological effects on phagocytes 
(17, 18), and that the chemoattractant 
N-formyl-methionine-leucine-phenylala-
nine (fMLP) (19) inhibits neutrophil migra-
tion in fibrin-containing matrices, but not 
in collagen matrices, prompted Li et al. to 
examine neutrophil-bactericidal activity in 
tissues and tissue-like environments (20). 
Figure 1
Comparative behaviors of bacterial populations at or near the CNC, as predicted by the 
equations of Li et al. (20, 21) and Malka et al. (25). (A) Li et al. derived an equation that 
includes an experimentally determined bacterial killing constant and the bacterial growth rate 
(20, 21). It predicts the CNC is constant at all B values. Their experiments show, however, 
that the bacterial growth rate and killing constant decrease, and the CNC increases (curved 
dashed line), at B values greater than 107 CFU/ml in stirred suspension and greater than 106 
CFU/ml in fibrin gel (not shown). Most importantly, this equation predicts B will decrease or 
increase at all N values below or above the CNC, respectively, and remain constant at the 
CNC. (B) In contrast, as reported here by Malka et al., the bacterial population is bistable at 
N at or very near the CNC, creating favorable conditions for uncontrolled bacterial growth 
(25). N1 and N2 and the dashed line indicate the N and B values that define the zone of 
bistability in the bacterial population. For N below the CNC (solid yellow line), the bacterial 
population grows exponentially. Note also that in fibrin gels and rabbit dermis, the CNC at all 
N values is at least 2-fold larger than in stirred suspensions, a reflection of the effect of the 
former environment on the bacterial killing constant.
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the effector activities of all immune cells. 
Consistent with this idea, Babbs (31) and 
Lejune et al. (32) report bistability of tumor 
cell growth under conditions in which the 
intratumoral concentration of tumor anti-
gen-specific CD8+ T cells fluctuates around 
the critical CD8+ T cell concentration.
Conclusions
Malka et al. have derived a dynamic system 
model (25, 26) that describes neutrophil- 
bactericidal activity in stirred solutions 
more accurately than did its linear pre-
decessor (20, 21). Although further work 
is needed to determine whether the vari-
ability in bactericidal activity described 
for neutrophils from normal adults 
applies to neutrophils from neutropenic 
and/or cytotoxic drug–treated patients, 
this model may enable clinicians to bet-
ter distinguish patients who are at risk of 
infection from those who are not, thereby 
reducing the morbidity, mortality, and 
expense associated with unnecessary hos-
pitalizations and/or administration of 
antibiotics and/or G-CSF.
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showed that the kinetics of neutrophil-
bactericidal activity in these gels closely 
mimics that for neutrophils in tissues in 
vivo (20). Third, Malka et al. ascribed the 
variability they observed in killing of S. 
aureus to differences in bactericidal activ-
ity of neutrophils from different healthy 
adult donors (25). However, their stud-
ies used 10% autologous serum, close 
to the concentration at which opsonin 
concentration becomes limiting (21, 27); 
20%–40% serum would have been a bet-
ter choice (21). Moreover, Malka et al. 
did not control for variations in opsonin 
concentration in each leukocyte donor’s 
serum. Thus, the variations in killing 
efficiencies observed could reflect varia-
tions in serum opsonin concentrations 
(27, 28), not in neutrophil bactericidal 
activity. From both mechanistic and 
practical standpoints, this is an impor-
tant matter to resolve.
Clinical experience now suggests that 
the use of G-CSF to prevent bone mar-
row–depressive effects of chemotherapy 
in patients at high risk for neutropenia is 
far more efficacious than using it to treat 
neutropenia once it has occurred (8, 29). 
Accordingly, it may be that the most use-
ful clinical application of this new equa-
tion will be to use it prospectively in con-
junction with other predictive tools (29), 
including low-tech methods such as the 
one devised by Wright et al. (12), to assess 
the likelihood that chemotherapy will 
cause the tissue bactericidal activity of a 
patient’s neutrophils to fall below the CNC 
and/or into regions of bacterial bistability.
These concerns notwithstanding, we 
believe the findings that neutrophil-bacteri-
cidal activity can be described by equations 
very similar to those describing enzyme-
substrate interactions provide an entirely 
new and quantitative way of viewing cel-
lular defense against microbial pathogens. 
Budhu et al. reported that the equation 
described by Li et al. (21) also describes 
antigen-specific CD8+ T cell killing of cog-
nate antigen–expressing melanoma cells in 
vitro and in living mice (30), which suggests 
that the same physical principles that gov-
ern neutrophil-bacterial interactions also 
govern the interactions of cytolytic lympho-
cytes with eukaryotic target cells. Indeed, it 
seems likely that these principles govern 
The equation’s quadratic term represents 
the killing rate (–αNB(t)/[1 + γB(t) + ηN]). It 
involves the law of mass action: the neutro-
phil-bactericidal rate is proportional (α) to 
the product of N and B multiplied by the 
amount of time (t; in minutes) the neutro-
phils interact with bacteria. It saturates at 
high concentrations of both neutrophils 
(ηN) and bacteria (γB). The system yields 
two very different outcomes depending 
on the magnitude of the initial param-
eters: it is monostable when N is well above 
or below the critical concentration, but 
becomes bistable when N fluctuates close 
to the CNC. Bistability is a characteristic 
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coexisting fixed points exist for a range of 
parameters (Figure 1B), and the system’s 
outcome depends on its initial conditions.
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est relevance for neutropenic patients (8, 
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